Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: PYRIDAZINES - THERAPEUTIC USE , . Treffer: 10
2017
Mehta, RH; Leimberger, JD; van Diepen, S; Meza, J; Wang, A; Jankowich, R; Harrison, RW; Hay, D; Fremes, S; Duncan, A; Soltesz, EG; Luber, J; Park, S; Argenziano, M; Murphy, E; Marcel, R; Kalavrouziotis, D; Nagpal, D; Bozinovski, J; Toller, W; Heringlake, M; Goodman, SG; Levy, JH; Harrington, RA; Anstrom, KJ; Alexander, JH; LEVO-CTS Investigators
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
NEW ENGL J MED. 2017; 376(21): 2032-2042.
Doi: 10.1056/NEJMoa1616218
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Fruhwald, S; Pollesello, P; Fruhwald, F
Advanced heart failure: an appraisal of the potential of levosimendan in this end-stage scenario and some related ethical considerations.
Expert Rev Cardiovasc Ther. 2016; 14(12):1335-1347
Doi: 10.1080/14779072.2016.1247694
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Galiè, N; Barberà, JA; Frost, AE; Ghofrani, HA; Hoeper, MM; McLaughlin, VV; Peacock, AJ; Simonneau, G; Vachiery, JL; Grünig, E; Oudiz, RJ; Vonk-Noordegraaf, A; White, RJ; Blair, C; Gillies, H; Miller, KL; Harris, JH; Langley, J; Rubin, LJ; AMBITION Investigators
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
N Engl J Med. 2015; 373(9):834-844
Doi: 10.1056/NEJMoa1413687
Web of Science
PubMed
FullText
FullText_MUG
Toller, W; Heringlake, M; Guarracino, F; Algotsson, L; Alvarez, J; Argyriadou, H; Ben-Gal, T; Černý, V; Cholley, B; Eremenko, A; Guerrero-Orriach, JL; Järvelä, K; Karanovic, N; Kivikko, M; Lahtinen, P; Lomivorotov, V; Mehta, RH; Mušič, Š; Pollesello, P; Rex, S; Riha, H; Rudiger, A; Salmenperä, M; Szudi, L; Tritapepe, L; Wyncoll, D; Öwall, A
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion.
Int J Cardiol. 2015; 184(5):323-336
Doi: 10.1016/j.ijcard.2015.02.022
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Fritz, JS; Blair, C; Oudiz, RJ; Dufton, C; Olschewski, H; Despain, D; Gillies, H; Kawut, SM;
Baseline and Follow-up 6-Min Walk Distance and Brain Natriuretic Peptide Predict 2-Year Mortality in Pulmonary Arterial Hypertension.
CHEST. 2013; 143(2): 315-323.
Doi: 10.1378/chest.12-0270
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Raghu, G; Behr, J; Brown, KK; Egan, JJ; Kawut, SM; Flaherty, KR; Martinez, FJ; Nathan, SD; Wells, AU; Collard, HR; Costabel, U; Richeldi, L; de Andrade, J; Khalil, N; Morrison, LD; Lederer, DJ; Shao, L; Li, X; Pedersen, PS; Montgomery, AB; Chien, JW; O'Riordan, TG; ARTEMIS-IPF Investigators*
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
Ann Intern Med. 2013; 158(9):641-649
Doi: 10.7326/0003-4819-158-9-201305070-00003
Web of Science
PubMed
FullText
FullText_MUG
Toller, W; Algotsson, L; Guarracino, F; Hörmann, C; Knotzer, J; Lehmann, A; Rajek, A; Salmenperä, M; Schirmer, U; Tritapepe, L; Weis, F; Landoni, G
Perioperative Use of Levosimendan: Best Practice in Operative Settings.
J Cardiothorac Vasc Anesth. 2013; 27(2):361-366
Doi: 10.1053/j.jvca.2012.04.007
Web of Science
PubMed
FullText
FullText_MUG
2012
Lechner, E; Hofer, A; Leitner-Peneder, G; Freynschlag, R; Mair, R; Weinzettel, R; Rehak, P; Gombotz, H
Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: A pilot study.
Pediatr Crit Care Med. 2012; 13(5):542-548
Doi: 10.1097/PCC.0b013e3182455571
Web of Science
PubMed
FullText
FullText_MUG
2009
McGoon, MD; Frost, AE; Oudiz, RJ; Badesch, DB; Galie, N; Olschewski, H; McLaughlin, VV; Gerber, MJ; Dufton, C; Despain, DJ; Rubin, LJ
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.
Chest. 2009; 135(1): 122-129.
Doi: 10.1378/chest.08-1028
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2006
Krumnikl, JJ; Toller, WG; Prenner, G; Metzler, H
Beneficial outcome after prostaglandin-induced post-partum cardiac arrest using levosimendan and extracorporeal membrane oxygenation.
ACTA ANAESTHESIOL SCAND. 2006; 50(6): 768-770.
Doi: 10.1111/j.1399-6576.2006.01034.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG